研報掘金丨華鑫證券:維持頂點軟件“買入”評級,“AI+信創”推動公司持續發展
華鑫證券研報指出,頂點軟件業績穩步增長,“AI+信創”推動公司持續發展。新交易體系業務是公司最核心的業務板塊,公司是新一代信創技術路線的開創者與引領者。公司攜手華爲、騰訊雲等廠商發佈了HTS2X純血信創版,實現了國產軟硬件的全棧信創以及全鏈路的深度優化,爲專業交易提供了有力支持。基於自主研發的“3+1”核心技術平臺,全方位深化各類應用的迭代升級,爲業務創新發展賦能。維持“買入”投資評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.